CIK 0001622229 · Large accelerated filer
Cogent Biosciences, Inc.
Sign in to watch- Ticker
- COGT
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 465308248
- Phone
- 617-945-5576
- Business address
- 180 THIRD AVENUE, 4TH FLOOR, WALTHAM, MA
- Former names
- Unum Therapeutics Inc., Unum Therapeutics, Inc.
- 4 Open-market buy 10% owner bought 1,200,000 shares at $8.25 ($9,900,000)
- SC 13G Stake Amended Statement of Ownership
- 8-K/A Event Material agreement · Other events
- 8-K Event Material agreement
- 424B5 Offering Prospectus
- FWP Offering Free Writing Prospectus
- 424B5 Offering Prospectus
- 8-K Event Shareholder vote results · Other events
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- EFFECT Other Notice of Effectiveness
- CORRESP Other Correspondence Between Filers and SEC Staff
- UPLOAD Other SEC-generated Letter
- EFFECT Other Notice of Effectiveness
- 10-Q Report Quarterly Report
- 8-K Event Results of operations
Page 14 of 31 · 616 filings